ArticleBone marrow transplantation2017

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission.

F Saraceni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.